Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

Korea Arlico Pharm Revenue

Korea Arlico Pharm had revenue of 46.85B KRW in the quarter ending June 30, 2026, a decrease of -6.84%. This brings the company's revenue in the last twelve months to 195.70B, down -3.04% year-over-year. In the year 2025, Korea Arlico Pharm had annual revenue of 201.20B with 5.65% growth.

• Revenue (ttm): 195.70B
• Revenue Growth: -3.04%
• P/S Ratio: 0.19
• Revenue / Employee: 1.75B
• Employees: 112
• Market Cap: 38.01B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	201.20B	10.77B	5.65%
Dec 31, 2024	190.44B	3.28B	1.75%
Dec 31, 2023	187.15B	19.42B	11.58%
Dec 31, 2022	167.74B	27.58B	19.68%
Dec 31, 2021	140.16B	15.35B	12.30%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error